AwardedCzechiaGoods
Léčivé přípravky s obsahem inotuzumab ozogamicinu, trastuzumabu, nivolumabu, ipilimumabu, amivantanabu, mosunetuzumabu
- Published
- Published 23 February 2026
- Deadline
- Closed 24 March 2026
Overview
Předmětem veřejné zakázky jsou průběžné dodávky léčivých přípravků s obsahem inotuzumab ozogamicinu, trastuzumabu, nivolumabu, ipilimumabu, amivantanabu, mosunetuzumabu po dobu 4 let dle aktuálních potřeb zadavatele.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Procedure
- Open
- Published
- 23 February 2026
- Deadline
- Closed
Antineoplastic agents
Award outcome
- Awarded value
- CZK 534,144,838
- Award date
- 8 April 2026
- Contract period
- — → 7 April 2030
- Bristol-Myers Squibb spol. s r.o.
- Janssen-Cilag s.r.o.
- PHARMOS, a.s.
- PHOENIX lékárenský velkoobchod, s.r.o.
- ROCHE s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
27 May 2026
Contract Notice
23 February 2026
Contracting authority
Fakultní nemocnice Hradec Králové
Procuring entityHradec Králové, Czechia
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.